Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
SPRO compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name
SPRO
Spero Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
SPRO
Spero Therapeutics, Inc.
vs
LLY
ELI Lilly & Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Co-movers
Desk
News
Calendar
Saved
Search
SPRO
Spero Therapeutics, Inc.
Change
1.05
▲
+0.48%
· post 1.05
Mkt cap
$60.6M
Revenue
$258,000
Q1 FY26
Revenue
$67M
FY25
LLY
ELI Lilly & Co
Change
1,407.25
▼
−0.27%
· post 1,416.42
Closed
Nov 3 '26
Mkt cap
$1.3T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
vs
Compare
Closed
Nov 3 '26
SPRO
Spero Therapeutics, Inc.
vs
LLY
ELI Lilly & Co
1.05
▲
+0.48%
post 1.05
Price
1,407.25
▼
−0.27%
post 1,416.42
$60.6M
Mkt cap
$1.3T
Q1 FY26
$258,000
Revenue
$24.4B
Q3 FY26
FY25
$67M
Revenue
$65.2B
FY25
Change
Change
SPRO
1.05
▲
+0.48%
vs
LLY
1,407.25
▼
−0.27%
Closed
Nov 3 '26
Co-movers
daily closes
Method
›
Moved together
SPRO
with
LLY
No shared trading history for SPRO and LLY.
Shared co-movers: not yet measured (SPRO).
SPRO, solid
LLY, hatched
r = correlation
Bar = r to r 0.75
Source: daily closes